Adnexal Diseases  >>  ENMD-2076  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ENMD-2076 / CASI
NCT01104675: Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer

Checkmark In ovarian clear cell cancer
Jan 2014 - Jan 2014: In ovarian clear cell cancer
Checkmark P2 data
Aug 2012 - Aug 2012: P2 data
Checkmark P2 data
More
Completed
2
64
US, Canada
ENMD-2076
CASI Pharmaceuticals, Inc.
Ovarian Cancer, Fallopian Cancer, Peritoneal Cancer
08/11
12/12

Download Options